Autopsy report · NCT06688370
The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up Study
Cause of deathSlow enrollment
“Due to difficulty in recruiting patients, the Sponsor decided to prematurely stop the study”
Life of this trial
- Ran for about 8 months before it stopped.
- 12 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Pierre Fabre Medicament
- Sponsor type
- Industry
- Conditions
- Sore-throat; Cough
- Interventions
- Petit Drill
- Participants
- 12
- Sites
- 1
- Countries
- France
Trials that died the same way
- MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV
“The recruitment was stopped prematurely by the sponsor in accordance with the principal investigator because of the difficulties to recruit patients and to achieve the planned numbers of patients within a reasonable time frame.” - Predictive Value of Pre-TAVI Infrahissian Conduction Time in the Occurrence of Complete Atrioventricular Block
“The sponsor, in consultation with the coordinating investigator, had decided to stop enrolment prematurely because the enrolment rate would not have made it possible to reach the target of 142 patients without increasing the duration of the study” - High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery
“Study halted prematurely, prior to enrollment of first patient, due to recruiting problems.” - A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
“Due to low enrollment, the Sponsor decided to prematurely terminate the study” - the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period
“the sponsor decided to stop the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.